(Q37862739)

24 August 2017

1 reference

title

Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity (English)

1 reference

24 August 2017

0 references

1 reference

7

1 reference

24 August 2017

José Ag Agúndez

1

1 reference

24 August 2017

María Isabel Lucena

2

1 reference

24 August 2017

Carmen Martínez

3

1 reference

24 August 2017

Raúl J Andrade

4

1 reference

24 August 2017

Miguel Blanca

5

1 reference

24 August 2017

Pedro Ayuso

6

1 reference

24 August 2017

language of work or name

English

0 references

publication date

8 April 2011

1 reference

Expert Opinion on Drug Metabolism & Toxicology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

817-828

1 reference

Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III).

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Hepatotoxicity associated with non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Review article: drug-induced liver injury in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Incidence of drug-induced hepatic injuries: a French population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Outcome and prognostic markers in severe drug-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Pharmacogenomics in drug induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Risk factors for idiosyncratic drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Criteria of drug-induced liver disorders. Report of an international consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Drug-induced liver injury: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Idiosyncratic drug hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Current concepts of mechanisms in drug-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Pharmacogenetics of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Drug-induced liver injury: past, present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Pharmacogenomics in aspirin intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Cytochrome P450 gene polymorphism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Five novel single nucleotide polymorphisms in the CYP2C8 gene, one of which induces a frame-shift.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Leflunomide-induced acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Polymorphic drug metabolism in anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Genetic Polymorphisms in the 5′-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P450IIE1 Gene1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Variability in ethanol biodisposition in whites is modulated by polymorphisms in the ADH1B and ADH1C genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Single nucleotide polymorphisms and microsatellite alleles of tumor necrosis factor alpha and interleukin-10 genes and the risk of advanced chronic alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Oxidative stress is important in the pathogenesis of liver injury induced by sulindac and lipopolysaccharide cotreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Nimesulide-induced hepatic mitochondrial injury in heterozygous Sod2(+/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Phenomics: the next challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Glutathione S-transferase GSTT1 and GSTM1 allozymes: beyond null alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Unraveling ambiguous NAT2 genotyping data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Hypersensitivity reactions to non-steroidal anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Histamine pharmacogenomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Variability of the L-Histidine decarboxylase gene in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

A decade of advances in metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.574613

10.1517/17425255.2011.574613

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference